Trial Profile
The use of xenon and dexmedetomidine for the prevention of postoperative emergence delirium after anaesthesia for pediatric cardiac catheterization: A randomized, controlled, observer-blinded pilot trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2020
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Xenon (Primary) ; Sevoflurane
- Indications Delirium; Postoperative complications
- Focus Therapeutic Use
- 12 Dec 2020 Status changed from recruiting to completed.
- 03 Apr 2020 Trial design published in the Trials
- 06 Oct 2018 Status changed from not stated to recruiting.